Evidence map›Paper›PMID 19649678›Full record

Trial reportJournal of general internal medicine2009

Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey.

Mara A Schonberg, Roger B Davis, Ellen P McCarthy, Edward R Marcantonio

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of general internal medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Guideline
  2. Pooled it
  3. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018
    Guideline
  4. Guideline
  5. Guideline
  6. Guideline
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. External validation of a prognostic model in routine practice for short- and long-term survival in peritoneal dialysis.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mara A SchonbergDivision of General Medicine and Primary Care, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 1309 Beacon, Brookline, Boston, MA, USA. mschonbe@bidmc.harvard.edu
Roger B Davis
Ellen P McCarthy
Edward R Marcantonio

Funding

Benefits and Burdens of Screening Oldest-old Women: the Case of MammographyK23AG028584 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHONBERG, MARA A · 2007 to 2008
$313k
NIA NIH HHS K23 AG 028584NIA NIH HHS K23 AG028584
6 · The paper itself

Abstract

backgroundPrognostic information is becoming increasingly important for clinical decision-making.

objectiveTo develop and validate an index to predict 5-year mortality among community-dwelling older adults. DESIGN AND

participantsA total of 24,115 individuals aged >65 who responded to the 1997-2000 National Health Interview Survey (NHIS) with follow-up through 31 December 2002 from the National Death Index; 16,077 were randomly selected for the development cohort and 8,038 for the validation cohort. MEASUREMENTS: 39 risk factors (functional measures, illnesses, behaviors, demographics) were included in a multivariable Cox proportional hazards model to determine factors independently associated with mortality. Risk scores were calculated for participants using points derived from the final model's beta coefficients. To evaluate external validity, we compared survival by quintile of risk between the development and validation cohorts.

resultsSeventeen percent of participants had died by the end of the study. The final model included 11 variables: age (1 point for 70-74 up to 7 points for >85); male: 3 points; BMI <25: 2 points; perceived health (good: 1 point, fair/poor: 2 points); emphysema: 2 points; cancer: 2 points; diabetes: 2 points; dependent in instrumental activities of daily living: 2 points; difficulty walking: 3 points; smoker-former: 1 point, smoker-current: 3 points; past year hospitalizations-one: 1 point, >2: 3 points. We observed close agreement between 5-year mortality in the two cohorts; which ranged from 5% in the lowest risk quintile to 50% in the highest risk quintile in the validation cohort.

conclusionsThis validated mortality index can be used to account for participant life expectancy in analyses using NHIS data.

Indexed as

Health Status IndicatorsHealth SurveysMortalityResidence CharacteristicsAgedAged, 80 and overAge FactorsCohort StudiesFemaleFollow-Up StudiesForecastingHumansMaleReproducibility of ResultsStatistics as TopicSurvival Rate

Identifiers

PMID19649678
PMCPMC2762505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.